Jazz Pharmaceuticals plc

BRSE:J7Z Stock Report

Market Cap: CHF 7.4b

Jazz Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BRSE:J7Z Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Dec 24SellCHF 5,755Patricia CarrIndividual53CHF 108.58
08 Nov 24SellCHF 399,225Neena PatilIndividual3,700CHF 107.90
06 Sep 24SellCHF 128,492Mary HendersonIndividual1,410CHF 91.13
07 Jun 24SellCHF 15,897Patricia CarrIndividual163CHF 97.53
03 May 24SellCHF 495,974Neena PatilIndividual5,000CHF 99.19
07 Mar 24SellCHF 384,975Patricia CarrIndividual3,704CHF 106.11
01 Mar 24BuyCHF 1,270,870Philip JohnsonIndividual12,000CHF 105.91

Insider Trading Volume

Insider Buying: J7Z insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of J7Z?
Owner TypeNumber of SharesOwnership Percentage
State or Government56,7220.0911%
Individual Insiders1,745,3352.8%
Institutions60,491,71697.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 66.77% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.98%
The Vanguard Group, Inc.
6,036,183CHF 736.5m-1.17%0.01%
9.68%
BlackRock, Inc.
5,851,226CHF 714.0m-0.36%0.01%
4.19%
LSV Asset Management
2,531,050CHF 308.8m1.49%0.67%
3.66%
Pacer Advisors, Inc.
2,214,480CHF 270.2m5.48%0.66%
3.37%
Dimensional Fund Advisors LP
2,035,070CHF 248.3m18.7%0.04%
3.26%
State Street Global Advisors, Inc.
1,968,822CHF 240.2m1.16%0.01%
3.18%
Capital Research and Management Company
1,923,342CHF 234.7m5.73%0.01%
3.02%
Columbia Management Investment Advisers, LLC
1,827,658CHF 223.0m20.9%0.05%
2.82%
EcoR1 Capital, LLC
1,706,469CHF 208.2m0%9.96%
2.37%
JP Morgan Asset Management
1,433,985CHF 175.0m5.44%0.02%
1.93%
Seamus Mulligan
1,169,300CHF 142.7m0%no data
1.9%
Camber Capital Management LP
1,150,000CHF 140.3m0%5.87%
1.81%
Geode Capital Management, LLC
1,093,442CHF 133.4m-1.91%0.01%
1.8%
Polaris Capital Management, LLC
1,085,860CHF 132.5m-16.8%2.17%
1.66%
Swedbank Robur Fonder AB
1,001,932CHF 122.3m0%0.08%
1.66%
Renaissance Technologies LLC
1,001,874CHF 122.2m-4.58%0.19%
1.61%
Vestal Point Capital, LP
975,000CHF 119.0m8.33%7.93%
1.55%
Fuller & Thaler Asset Management, Inc.
939,351CHF 114.6m117%0.47%
1.16%
Thompson, Siegel & Walmsley LLC
700,922CHF 85.5m-10.3%1.04%
1.09%
FMR LLC
659,181CHF 80.4m-14.3%0.01%
1.09%
Franklin Resources, Inc.
656,441CHF 80.1m-40.4%0.03%
1.02%
Millennium Management LLC
616,069CHF 75.2m-6.19%0.07%
1.02%
Charles Schwab Investment Management, Inc.
615,517CHF 75.1m15.8%0.01%
0.98%
JOHCM (USA) Inc
594,388CHF 72.5m-12%1.14%
0.95%
AQR Capital Management, LLC
575,074CHF 70.2m3.92%0.1%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/22 01:01
End of Day Share Price 2025/02/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Jazz Pharmaceuticals plc is covered by 51 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joel BeattyBaird
Ishan MajumdarBaptista Research
Richard SilverBarclays